Carbon Energy Corp - FORM 10-Q

Attached files

file	filename
EX-31.1 - EXHIBIT 31.1 - Carbon Energy Corp	stls_10q123109ex311.htm
EX-32.1 - EXHIBIT 32.1 - Carbon Energy Corp	stls_10q123109ex321.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

[ X ]

QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

for the quarterly period ended December 31, 2009

[ ]	TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE EXCHANGE ACT for the transition period from ____________ to ____________

Commission File Number 000-02040

ST. LAWRENCE SEAWAY CORPORATION

(Exact Name of Small Business Issuer as Specified in its Charter)

DELAWARE	26-0818050
(State or Other Jurisdiction of Incorporation or Organization)	(I.R.S. Employer Identification No.)

200 Connecticut Avenue

Fifth Floor

Norwalk, Connecticut 06854

(Address of principal executive offices)

(203) 853-8700

(Issuer’s Telephone Number, Including Area Code)

Indicate by check whether the registrant: (1) filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes [ X ] No [ ]

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” I Rule 12B-2 of the Exchange Act. (Check one)

Larger accelerated filer o Accelerated filer o Non-accelerated filer o Smaller reporting company þ

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes [ X ] No [ ]

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (ss.232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files)

Yes [ ] No [ ]

State the number of shares outstanding of the issuer’s common stock.

Class	Outstanding at January 29, 2010
Common Stock, $0.01 par value	518,736

ST. LAWRENCE SEAWAY CORPORATION

FORM 10-Q INDEX

		PAGE

PART I. RECENT DEVELOPMENTS AND FINANCIAL INFORMATION

Recent Developments		1 - 2

Item 1. Financial Statements

	Balance Sheets – December 31, 2009 (unaudited) and March 31, 2009 (audited)	3

	Statements of Operations – Three months ended December 31, 2009 (unaudited) and three months ended December 31, 2008 (unaudited)	4

	Statements of Operations – Nine months ended December 31, 2009 (unaudited) and nine months ended December 31, 2008 (unaudited)	5

	Statement of Changes in Stockholders’ Equity – Nine months ended December 31, 2009 (unaudited)	6

	Statements of Cash Flows – Nine months ended December 31, 2009 (unaudited) and nine months ended December 31, 2008 (unaudited)	7

	Notes to Financial Statements – December 31, 2009	8-14

Item 2. Management’s discussion and analysis of financial condition and result of operation		14

FORWARD LOOKING STATEMENTS		15

Item 3. Controls and Procedures		16

PART II. OTHER INFORMATION		16

Exhibit Index		17

Signature Page		18

Exhibits

PART I. RECENT DEVELOPMENTS AND FINANCIAL INFORMATION

RECENT DEVELOPMENTS

A) The Company entered into a Stock and Warrant Purchase Agreement (the "Purchase Agreement") as of January 10, 2007, as amended on April 16, 2007 and April 18, 2007, with Bernard Zimmerman & Company, Inc., an investment and merchant banking organization (the "Investor"), pursuant to which the Investor agreed to purchase: (i) 75,000 shares of the Company's common stock for a total purchase price of $75,000; and (ii) a ten year warrant for a total purchase price of $2,500 which permits the Investor to purchase up to 250,000 shares of the Company's common stock at an exercise price of $1.00 per share (the "Warrant"). The Warrant is exercisable immediately. The common stock and the Warrant were sold to the Investor pursuant to an exemption from registration under Section 4(2) of the Securities Act of 1933, as amended. The common stock that was sold to the Investor represented at the August 31, 2007 closing of this transaction, and continues to represent as of the date hereof, approximately 14.5% of the outstanding common stock of the Company, provided that no changes occur to the number of shares outstanding in subsequent periods.

On July 10, 2007, the shareholders of the Company approved the transaction outlined in the above paragraph. An integral part of the transaction were the following items:

	1.	The approval of a proposal to amend and restate, in its entirety, the Company’s by-laws.

	2.	The approval of a proposal to reincorporate the Company in Delaware from Indiana.

	3.	The approval of a proposal to amend and restate in its entirety the Company’s Restated Articles of Incorporation, as amended, to, among other things:

	(a) approve the increase in the number of authorized shares of the Company from 4,000,000 shares, all of which are Common Stock, to 50,010,000 shares, consisting of 48,500,000 shares of Common Stock, 510,000 shares of a “tracking stock” known as Class A Common Stock and 1,000,000 shares of preferred stock, and to decrease the par value of the Common Stock from One Dollar ($1.00) to One Cent ($0.01);

	(b) approve the authorization of 1,000,000 shares of a blank check preferred class of stock, par value $0.01; and

	(c) approve the authorization of a non-transferable, non-tradable, non-voting and non-certificated “tracking stock” class of securities known as the Class A Common Stock;

	4.	The issuance of the “tracking stock” known as the Class A Common Stock to the Record Holders in connection with, and upon consummation of the transaction described above, which closed after the distribution of the Class A Common Stock to existing shareholders, and, as such, the Investor received no “tracking stock”.

Immediately prior to the August 31, 2007 closing under the Purchase Agreement, the Company reincorporated in Delaware via statutory merger and issued to all stockholders of record as of that date a tracking stock evidencing the Company's medical investments. The tracking stock, designated as Class A Common Stock, is non-voting, non-saleable, non-transferable, non-certificated and held in book-entry form only. The Purchase Agreement contemplates no issuance of Class A Common Stock to the Investor in connection with the Investor's acquisition of the Company's common stock and the Warrant on August 31, 2007. No person who acquires common stock of the Company after August 31, 2007 shall be issued or be entitled to the benefits of the tracking stock. For additional terms and conditions of the Purchase Agreement (including the proposals to reincorporate in Delaware and to issue the tracking stock), please see the Company's Form 8-K filed on January 10, 2007, the Company's Form 8-K filed on April 19, 2007, and the Company’s proxy statement, filed on May 30, 2007 concerning the proposals that were voted upon and approved at the stockholders’ meeting held on July 10, 2007.

In connection with the closing under the Purchase Agreement, and in accordance with the vote of a majority of shareholders of the Company, the incorporator of the surviving Company named Mssrs. Bernard Zimmerman (the principal of the Investor), Ronald. A. Zlatniski, Duane L. Berlin and Edward B. Grier as members of the Company’s Board of Directors. Following the closing under the Purchase Agreement, Mr. Zimmerman was appointed by the Board of Directors as Chairman of the Board of Directors, President, Chief Financial Officer and Treasurer, and Mr. Berlin was appointed as Secretary.

B) On January 21, 2010, the St. Lawrence Seaway Corporation (the “Company”) entered into a Unit Purchase and Mutual Release Agreement with T-3 Therapeutics, LLC (“T-3”) for the sale of the Company’s entire membership interest in T-3 for $100,000 (the “Agreement”), payable in cash upon execution of the Agreement.

Disclosure of the Company’s establishment of its Class A Tracking Stock (representing the Company’s medical-related investments, which include its New York University Research Funding investment, which has been deemed of no value, and its T-3 investment), held in street name only and owned by those shareholders of record as of August 31, 2007 entitled to future proceeds from the sale of the Company’s medical investments, was set forth in the Company’s definitive Proxy Statement on Schedule 14A, filed with the Securities and Exchange Commission on May 30, 2007. On August 31, 2007, there were outstanding 443,736 shares of Class A Tracking Stock.

On January 21, 2010, the Company’s Board of Directors approved the redemption of all of the Company’s issued and outstanding Class A Tracking Stock for $0.19 per share, after deducting current and anticipated expenses. The redemption will be effectuated on March 12, 2010 to shareholders of record on August 31, 2007. The Company will use the nominal balance of cash available after the redemption to pay costs and expenses associated therewith.

See Form 8-K filed with the Securities and Exchange Commission on January 25, 2010 for complete information.

Item 1. Financial Statements

ST. LAWRENCE SEAWAY CORPORATION

BALANCE SHEETS

	At December 31, 2009			At March 31, 2009
	(unaudited)			(audited)
ASSETS

Current Assets:
Cash and cash equivalents	$	58,772		$	83,916
Accrued interest receivable		--			--
Total Current Assets		58,772			83,916

LIABILITIES AND SHAREHOLDERS' EQUITY

Current Liabilities:
Accounts payable & accrued expenses		5,000			6,000
Total Current Liabilities		5,000			6,000

Commitments and contingencies		--			--

Shareholders' Equity:

Preferred Stock, par value $0.01, 1,000,000 shares authorized, none issued or outstanding		--			--

Common stock, par value $0.01 per share; 48,500,000 shares authorized; 518,736 shares at 12/31/09 and at 3/31/09 issued and outstanding		5,188			5,188

Common stock, Class A (tracking), par value $0.01 per share; 510,000 shares authorized; 443,736 shares at 12/31/09 and at 3/31/09 issued and outstanding		4,437			4,437

Additional paid-in capital		1,481,365			1,481,365
Retained deficit		(1,437,218	)		(1,413,074	)
Total Shareholders' Equity		53,772			77,916
Total Liabilities and Shareholders' Equity	$	58,772		$	83,916

See Notes to the Financial Statements

ST. LAWRENCE SEAWAY CORPORATION

STATEMENTS OF OPERATIONS

(UNAUDITED)

	For the Three Months Ended
	December 31, 2009			December 31, 2008

Revenues:
Interest	$	202		$	508
Total revenues		202			508

Operating costs and expenses:
General and administrative		8,081			7,510
Total operating expenses		8,081			7,510
Loss before tax provision		(7,879	)		(7,002	)
Provision for income taxes		--			--
Net loss	$	(7,879	)	$	(7,002	)


Per share data:
Weighted average number of common shares outstanding basic and diluted		518,736			518,736


Basic and diluted loss per share	$	(0.02	)	$	(0.01	)

See Notes to the Financial Statements

ST. LAWRENCE SEAWAY CORPORATION

STATEMENTS OF OPERATIONS

(UNAUDITED)

	For the Nine Months Ended
	December 31, 2009			December 31, 2008

Revenues:
Interest	$	742		$	1,747
Total revenues		742			1,747

Operating costs and expenses:
General and administrative		24,846			22,765
Total operating expenses		24,886			22,765
Loss before tax provision		(24,144	)		(21,018	)
Provision for income taxes		--			--
Net Loss	$	(24,144	)	$	(21,018	)


Per share data:
Weighted average number of common shares outstanding basic and diluted		518,736			518,736


Basic and diluted loss per share	$	(0.05	)	$	(0.04	)

See Notes to the Financial Statements

ST. LAWRENCE SEAWAY CORPORATION

STATEMENT OF CHANGES IN STOCKHOLDERS’ EQUITY

	Class A		Common Stock				Paid-In			Accumulated			Total Stockholders’
	Shares		Shares		Amount		Capital			Deficit			Equity

Balance, March 31, 2007 (audited)			427,069	$	4,271	$	866,718		$	(755,493	)	$	115,496
Issuance of Class A Shares		443,736		$	4,437	$	(4,437	)					-
Sale of Warrants			--		--	$	2,500					$	2,500
Sale of Common Shares			75,000	$	750	$	74,250					$	75,000
Exercise of Warrants			16,667	$	167	$	49,834					$	50,001
Fair Value of Warrant Issuance						$	492,500					$	492,500
Net loss for the year ended March 31, 2008 (audited)									$	(626,880	)	$	(626,880	)
Balance March 31, 2008 (audited)		443,736	518,736	$	9,625	$	1,481,365		$	(1,382,373	)	$	108,617
Net loss for the year ended March 31, 2009 (audited)									$	(30,701	)	$	(30,701	)
Balance March 31, 2009 (audited)		443,736	518,736	$	9,625	$	1,481,365		$	(1,413,074	)	$	77,916
Net loss for the nine months ended December 31, 2009 (unaudited)									$	(24,144	)	$	(24,144	)
Balance December 31, 2009 (unaudited)		443,736	518,736	$	9,625	$	1,481,365		$	(1,437,218	)	$	53,772

See Notes to Financial Statements

ST. LAWRENCE SEAWAY CORPORATION

STATEMENTS OF CASH FLOWS

(UNAUDITED)

	For the Nine Months Ended

	December 31, 2009			December 31, 2008
Cash flows from operating activities
Net Loss	$	(24,144	)	$	(21,018	)

Adjustments to reconcile net loss to net cash from operating activities
Increase (Decrease) in current assets:
Interest and other receivables		--			--

(Decrease) Increase in current liabilities:
Accounts payable		(1,000	)		(4,000	)
Net cash used from operating activities		(25,144	)		(25,018	)

Cash flows from investing activities:
Net cash from investing activities		--			--

Cash flows from financing activities:
Net cash provided by financing activities		--			--

Net change in cash and cash equivalents		(25,144	)		(25,018	)

Cash and cash equivalents, beginning		83,916			116,617
Cash and cash equivalents, ending	$	58,772		$	91,599

Supplemental disclosures of cash flow information:
Cash paid for income taxes	$	--		$	--
Cash paid for interest expense	$	--		$	--

The Company issued 443,736 shares of Class A Common Stock (tracking stock) in accordance with the Purchase Agreement (see Note C) in a non-cash transaction.

See Notes to the Financial Statements

ST. LAWRENCE SEAWAY CORPORATION

NOTES TO THE FINANCIAL STATEMENTS

DECEMBER 31, 2009

(UNAUDITED)

NOTE A -- BASIS OF PRESENTATION

The accompanying unaudited financial statements have been prepared in accordance with generally accepted accounting principles for interim financial information and the instructions to Form 10-Q and Article 10-01 of Regulation S-X, promulgated by the Securities and Exchange Commission. Accordingly, they do not include all of the information and footnotes required for generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the nine-month period ending December 31, 2009 are not necessarily indicative of the results that may be expected for the fiscal year ending March 31, 2010. For further information, refer to the financial statements and footnotes thereto included in the Company's annual report on Form 10-K for the fiscal year ended March 31, 2009 and all subsequent filings with the Securities and Exchange Commission.

The preparation of financial statements in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect certain reported amounts and disclosures. Accordingly, actual results could differ from those estimates.

The financial statements have been prepared assuming the Company will continue as a going concern. Management believes that the Company has sufficient cash to continue its efforts to seek merger (including reverse merger) acquisition and business combination opportunities for more than the next twelve months. However, the Company has no operations, and has experienced recurring quarterly and annual losses which have significantly weakened the Company’s financial condition and its ability to meet current operating expenses. The appropriateness of using the going concern basis is dependent on, among other things, the Company’s ability to raise additional capital to fund operating losses, and to further reduce operating expenses. The uncertainty of obtaining these goals raises doubt about the Company’s ability to continue as a going concern through December 31, 2010. The financial statements do not include any adjustments to the carrying value of the assets and liabilities that might be necessary as a consequence of these uncertainties.

The Company has implemented all new accounting pronouncements that are in effect and that may impact our financial statements and do not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on our financial statements.

NOTE B – SHAREHOLDERS’ EQUITY AND EARNINGS PER SHARE

All share amounts have been retrospectively restated to reflect the reduction in par value from $1.00 to $0.01 based upon authorization by the Company’s shareholders (see Note C). Basic and diluted earnings per share are computed using the weighted average number of shares of common stock and common stock equivalents outstanding under the treasury stock method. Common stock equivalents include all common stock options and warrants outstanding during each of the periods presented. Earnings per share information associated with the Class A shares has not been presented as there were no earnings or losses associated with these shares; accordingly, such per share amounts are nil.

NOTE C – PURCHASE AGREEMENT

The Company entered into a Stock and Warrant Purchase Agreement (the "Purchase Agreement") as of January 10, 2007, as amended on April 16, 2007 and April 18, 2007, with Bernard Zimmerman & Company, Inc., an investment and merchant banking organization (the "Investor"), pursuant to which the Investor agreed to purchase: (i) 75,000 shares of the Company's common stock for a total purchase price of $75,000; and (ii) a ten year warrant for a total purchase price of $2,500 which permits the Investor to purchase up to 250,000 shares of the Company's common stock at an exercise price of $1.00 per share (the "Warrant"). The Warrant is exercisable immediately. The common stock and the Warrant were sold to the Investor pursuant to an exemption from registration under Section 4(2) of the Securities Act of 1933, as amended. The common stock that was sold to the Investor represented at the August 31, 2007 closing of this transaction, and continues to represent as of the date hereof, approximately 14.5% of the outstanding common stock of the Company, provided that no changes occur to the number of shares outstanding in subsequent periods.

On July 10, 2007, the shareholders of the Company approved the transaction outlined in the above paragraph. Integral parts of the transaction were the following items:

	1.	The approval of a proposal to amend and restate, in its entirety, the Company’s by-laws.

	2.	The approval of a proposal to reincorporate the Company in Delaware from Indiana.

	3.	The approval of a proposal to amend and restate in its entirety the Company’s Restated Articles of Incorporation, as amended, to, among other things:

	(a) approve the increase in the number of authorized shares of the Company from 4,000,000 shares, all of which are Common Stock, to 50,010,000 shares, consisting of 48,500,000 shares of Common Stock, 510,000 shares of a “tracking stock” known as Class A Common Stock and 1,000,000 shares of preferred stock, and to decrease the par value of the Common Stock from One Dollar ($1.00) to One Cent ($0.01);

	(b) approve the authorization of 1,000,000 shares of a blank check preferred class of stock, par value $0.01; and

	(c) approve the authorization of a non-transferable, non-tradable, non-voting and non-certificated “tracking stock” class of securities known as the Class A Common Stock;

	4.	The issuance of the “tracking stock” known as the Class A Common Stock to the Record Holders in connection with, and upon consummation of the transaction described above, which closed after the distribution of the Class A Common Stock to existing shareholders, and, as such, the Investor received no “tracking stock”.

NOTE D -- MEDICAL INVESTMENTS

In periods prior to March 31, 2007, the Company made certain investments in two medical research organizations. Reference is made to the Company’s 10-KSB for the fiscal year ending March 31, 2007 for a full description of the two medical investments. The investment in New York University Research was written off the Company’s books in the fiscal year ended March 31, 2005 as having no value. As a result of the Purchase Agreement (see Note C), the Company’s investment in T3 Therapeutics was written off at September 30, 2007. In accordance with the Purchase Agreement, a Class “A” common stock (a tracking stock) was issued to all Company stockholders of record except the Investor on August 31, 2007, the closing date of that transaction. All subsequent stockholders will not be entitled to receive any shares or benefits of the tracking stock, which is non-certificated, non-voting, non-transferable and non-saleable, and will be held only in book entry form in the records of the Company’s transfer agent. Any funds or other remuneration received from this investment will inure only to those persons who were stockholders of record, with the exception of the Investor, on August 31, 2007. Therefore, this investment is deemed to not have any current value and $83,400 was written off the Company’s financial statements as at the six months ended September 30, 2007. However, the Class A common stock (the “Tracking Stock”) that was allocated to the shareholders of the Company on August 31, 2007 will continue to be maintained on the books of the Company at the office of the Company’s registrar and transfer agent until such time as the Medical Investment is liquidated, permanently impaired or deemed worthless. At August 31, 2007, March 31, 2009, and December 31, 2009 there were 443,736 shares of Class A Common Stock issued and outstanding.

A reconciliation of the medical investments is as follows:

Balance March 31, 2005 (as restated)	$	680,000
Add: Follow-on investment, November 16, 2005	$	50,000
Subtotal	$	730,000
Less:	$
Impairment loss	$	(630,000	)
Equity in Loss of T3 Therapeutics	$	(16,600	)
Balance, March 31, 2007	$	83,400
Write off at September 30, 2007	$	(83,400	)
Balance at March 31, 2009 and December 31, 2009	$	-0-

As of August 31, 2007, the date of the closing of the transactions contemplated by the Purchase Agreement, and through the date hereof, Mr. Edward B. Grier, a current member of the Company’s board of directors, was a 2.5% owner of T-3 Therapeutics and had an option to purchase an additional ownership interest of approximately 2.5%, both of which he continues to own.

Please see Page 2 (Recent Developments) for information concerning the sale of the T-3 Therapeutics medical investment and the subsequent redemption of the Class A Tracking Stock.

NOTE E -- RECENTLY ISSUED ACCOUNTING PRONOUNCEMENTS:

In June 2009, the FASB issued Accounting Standards Update (“ASU”) No. 2009-01, Topic 105 — Generally Accepted Accounting Principles — amendments based on Statement of Financial Accounting Standards No. 168, The FASB Accounting Standards Codification and the Hierarchy of Generally Accepted Accounting Principles. This ASU reflected the issuance of FASB Statement No. 168. This Accounting Standards Update amends the FASB Accounting Standards Codification for the issuance of FASB Statement No. 168, The FASB Accounting Standards Codification ™ and the Hierarchy of Generally Accepted Accounting Principles. This Accounting Standards Update includes Statement 168 in its entirety, including the accounting standards update instructions contained in Appendix B of the Statement. The Codification does not change current U.S. GAAP, but is intended to simplify user access to all authoritative U.S. GAAP by providing all the authoritative literature related to a particular topic in one place. The Codification is effective for interim and annual periods ending after September 15, 2009, and as of the effective date, all existing accounting standard documents will be superseded. The Codification is effective for the Company in the second quarter of 2009, and accordingly, our Quarterly Report on Form 10-Q for the quarter ending September 30, 2009 and all subsequent public filings will reference the Codification as the sole source of authoritative literature.

In June 2009, the FASB issued Accounting Standards Update (“ASU”) No. 2009-02, Omnibus Update—Amendments to Various Topics for Technical Corrections. This omnibus ASU detailed amendments to various topics for technical corrections. The adoption of ASU 2009-02 will not have a material impact on the Company’s financial condition results of operation or cash flows.

In August 2009, the FASB issued Accounting Standards Update (“ASU”) No. 2009-03, SEC Update — Amendments to Various Topics Containing SEC Staff Accounting Bulletins. This ASU updated cross-references to Codification text. The adoption of ASU 2009-03 will not have a material impact on the Company’s financial condition results of operation or cash flows.

In August 2009, the FASB issued Accounting Standards Update (“ASU”) No. 2009-04, Accounting for Redeemable Equity Instruments — Amendment to Section 480-10-S99. This ASU represents an update to Section 480-10-S99, Distinguishing Liabilities from Equity, per Emerging Issues Task Force Topic D-98, “Classification and Measurement of Redeemable Securities.” The adoption of ASU 2009-04 will not have a material impact on the Company’s financial condition results of operation or cash flows.

In August 2009, the FASB issued Accounting Standards Update (“ASU”) No. 2009-05, Fair Value Measurements and Disclosures (Topic 820) — Measuring Liabilities at Fair Value. This Accounting Standards Update amends Subtopic 820-10, Fair Value Measurements and Disclosures-Overall, for the fair value measurement of liabilities. The adoption of ASU 2009-05 is not expected to have a material impact on the Company’s financial condition results of operation or cash flows.

In September 2009, the FASB issued Accounting Standards Update (“ASU”) No. 2009-06, Implementation Guidance on Accounting for Uncertainty in Income Taxes and Disclosure Amendments for Nonpublic Entities. This Accounting Standards Update provides additional implementation guidance on accounting for uncertainty in income taxes and eliminates the disclosures required by paragraph 740-10-50-15(a) through (b) for nonpublic entities. The adoption of ASU 2009-06 will not have a material impact on the Company’s financial condition results of operation or cash flows.

In September 2009, the FASB issued Accounting Standards Update (“ASU”) No. 2009-07, Technical Corrections to SEC Paragraphs. This Accounting Standards Update corrected SEC paragraphs in response to comment letters. The adoption of ASU 2009-07 will not have a material impact on the Company’s financial condition results of operation or cash flows.

In September 2009, the FASB issued Accounting Standards Update (“ASU”) No. 2009-08, Earnings Per Share Amendments to Section 260-10-S99. This Codification Update represents technical corrections to Topic 260-10-S99, Earnings per Share, based on EITF Topic D-53, Computation of Earnings Per Share for a Period that Includes a Redemption or an Induced Conversion of a Portion of a Class of Preferred Stock and EITF Topic D-42, The Effect of the Calculation of Earnings per Share for the Redemption or Induced Conversion of Preferred Stock. The adoption of ASU 2009-08 will not have a material impact on the Company’s financial condition results of operation or cash flows.

In September 2009, the FASB issued Accounting Standards Update (“ASU”) No. 2009-09, Accounting for Investments-Equity Method and Joint Ventures and Accounting for Equity-Based Payments to Non-Employees. This Accounting Standards Update represents a correction to Section 323-10-S99-4 and 505-50-S99-2. Accounting by an Investor for Stock-Based Compensation Granted to Employees of an Equity Method Investee. Section 323-10-S99-4 was originally entered into the Codification incorrectly. The adoption of ASU 2009-09 will not have a material impact on the Company’s financial condition results of operation or cash flows.

In September 2009, the FASB issued Accounting Standards Update (“ASU”) No. 2009-10, Financial Services-Brokers and Dealers: Investments-Other, Amendment to Subtopic 940-325. This Accounting Standards Update codifies the Observer comment in paragraph 17 of EITF 02-3, Issues Involved in Accounting for Derivative Contracts Held for Trading Purposes and Contracts Involved in Energy Trading and Risk Management. The adoption of ASU 2009-10 will not have a material impact on the Company’s financial condition results of operation or cash flows.

In September 2009, the FASB issued Accounting Standards Update (“ASU”) No. 2009-11, Extractive Activities-Oil and Gas, Amendment to Section 932-10-S99. This Accounting Standards Update represents a technical correction to the SEC Observer comment in EITF 90-22, Accounting for Gas-Balancing Arrangements. The adoption of ASU 2009-11 will not have a material impact on the Company’s financial condition results of operation or cash flows.

In September 2009, the FASB issued Accounting Standards Update (“ASU”) No. 2009-12, Fair Value Measurements and Disclosures (Topic 820), Investments in Certain Entities that Calculate Net Asset Value per Share (or Its Equivalent). This Accounting Standards Update amends Subtopic 820-10, Fair Value Measurements and Disclosures-Overall, to provide guidance on the fair value measurement of investments in certain entities that calculate net asset value per share (or its equivalent). The amendments in this Update are effective for interim and annual periods ending after December 15, 2009. The Company is currently evaluating the impact of ASU 2009-12 on the Company’s financial statements.

In October 2009, the FASB issued Accounting Standards Update (“ASU”) No. 2009-13, Revenue Recognition (Topic 605): Multiple Deliverable Revenue Arrangements-a consensus of the FASB Emerging Issue Task Force. This Accounting Standards Update amends Subtopic 605-25, separating consideration in multiple-deliverable arrangements. This amendment in this Update will be effective prospectively for revenue arrangements entered into or materially modified in fiscal years beginning on or after June 15, 2010. The Company is currently evaluating the impact of ASU 2009-13 on the Company’s financial statements.

In October 2009, the FASB issued Accounting Standards Update (“ASU”) No. 2009-14, Software (Topic 985): Certain Revenue Arrangements That Include Software Elements- a consensus of the FASB Emerging Issue Task Force. This Accounting Standards Update amends Subtopic 985-605, Software-Revenue Recognition. This amendment in this Update will be effective prospectively for revenue arrangements entered into or materially modified in fiscal years beginning on or after June 15, 2010. The Company is currently evaluating the impact of ASU 2009-14 on the Company’s financial statements.

In October 2009, the FASB issued Accounting Standards Update (“ASU”) No. 2009-15, Accounting for Own-Share Lending Arrangements in Contemplation of Convertible Debt Issuance or Other Financing (Topic 470). This Accounting Standards Update amends Subtopic 470-20, Debt with Conversion and Other Options and Subtopic 260-10, Earnings Per Share. The adoption of ASU 2009-15 will not have a material impact on the Company’s financial condition results of operation or cash flows.

In December 2009, the FASB issued Accounting Standards Update (“ASU”) No. 2009-16, Accounting for Transfers and Servicing (Topic 860). This Accounting Standards Update amends Subtopic 860-10, Transfers and Servicing-Overall. The adoption of ASU 2009-16 will not have a material impact on the Company’s financial condition results of operation or cash flows.

In December 2009, the FASB issued Accounting Standards Update (“ASU”) No. 2009-17, Accounting for Improvements to Financial Reporting by Enterprises Involved with Variable Interest Entities, (Topic 810). This Accounting Standards Update amends Subtopic 810-10, Consolidation-Overall and adds Participating Rights, Kick-out Rights and Protective Rights. The adoption of ASU 2009-17 will not have a material impact on the Company’s financial condition results of operation or cash flows.

In January 2010, the FASB issued Accounting Standards Update (“ASU”) No. 2010-01, Accounting for Distributions to Shareholders with Components of Stock and Cash-a consensus of the FASB Emerging Issues Task Force,(Topic 505). This Accounting Standards Update clarifies that the stock portion of a distribution to shareholders that allows them to elect to receive cash or stock with a potential limitation on the total amount of cash that all shareholders can elect to receive in the aggregate is considered a share issuance that is reflected in EPS prospectively and is not a stock dividend for purposes of applying Topics 505 and 260 (Equity and Earning Per Share). The Company is currently evaluating the impact of ASU 2010-01 on the Company’s financial statements.

In January 2010, the FASB issued Accounting Standards Update (“ASU”) No. 2010-02, Accounting and Reporting for Decreases in Ownership of a Subsidiary-a Scope Clarification, (Topic 810). This Accounting Standards Update establishes the accounting and reporting guidance for noncontrolling interests and changes in ownership interests of a subsidiary. The adoption of ASU 2010-02 will not have a material impact on the Company’s financial condition results of operation or cash flows.

In January 2010, the FASB issued Accounting Standards Update (“ASU”) No. 2010-03, Oil and Gas Reserve estimation and Disclosures, (Topic 932). This Accounting Standards Update improves the reserve estimation and disclosure requirements by (1) updating the reserve estimation requirements for changes in practice and technology that have occurred over the last several decades and (2) expanding the disclosure requirements for equity method investments. The adoption of ASU 2010-03 will not have a material impact on the Company’s financial condition results of operation or cash flows.

In January 2010, the FASB issued Accounting Standards Update (“ASU”) No. 2010-04, Accounting for Various Topics-Technical Corrections to SEC Paragraphs. The Company is currently evaluating the impact of ASU 2010-04 on the Company’s financial statements.

In January 2010, the FASB issued Accounting Standards Update (“ASU”) No. 2010-05, Escrowed Share Arrangements and the Presumption of Compensation, (Topic 718). The adoption of ASU 2010-03 will not have a material impact on the Company’s financial condition results of operation or cash flows.

The Company has implemented all new accounting pronouncements that are in effect and that may impact its financial statements and does not believe that there are any other new accounting pronouncements that have been issued that might have a material impact on its financial position or results of operations.

NOTE F – CONCENTRATIONS OF CREDIT RISK:

The Company’s financial instruments that are exposed to concentrations of credit risk consist primarily of cash and cash equivalents.

NOTE G – FAIR VALUE OF COMMON STOCK AND COMMON STOCK WARRANTS

The transaction entered into by the Company and the Investor on August 31, 2007 (see Note C) required the Company to issue 250,000 Warrants to the Investor, exercisable immediately, with an exercise price of $1.00 per warrant. The Warrants were sold to the Investor for $0.01 per warrant.

With regard to the sale and issuance of 75,000 common shares, the Company recorded such sale at fair value, which the Company believes to be $1.00 (the price paid by the Investor).

In accordance with FASB Accounting Standards Codification, “Compensation-Stock Compensation,” (ASC 718), the Company calculated the estimated fair value of warrants utilizing a Black-Scholes model. The assumptions used in the Black-Scholes model are based on the date the warrants are granted. The risk-free rate is based on US Treasury securities with a remaining term which approximates the estimated life assumed at the date of grant. The expected life until exercise was based on management’s estimate and the warrants ten year life. The following table includes the assumptions used in estimating fair values and the resulting weighted average fair value of warrants issued as part of the Purchase Agreement:

	Risk free rate	4.54%
	Warrant term	10 years
	Expected dividend rate	none
	Expected volatility	150%

Based on the Black-Scholes valuation method, the warrants were determined to have an estimated fair value of $1.98 per warrant at issuance. Accordingly, the Company recorded the difference between the estimated fair value of the warrant $495,000 and the cost of the warrant $2,500 as compensation expense and a corresponding increase to accumulated paid-in capital.

NOTE H - FAIR VALUE OF FINANCIAL INSTRUMENTS:

FASB Accounting Standards Codification, “Financial Instrument,” (ASC 825), requires disclosure of the fair value of financial instruments for which the determination of fair value is practicable. ASC 825 defines the fair value of a financial instrument as the amount at which the instrument could be exchanged in a current transaction between willing parties. The carrying amounts of the Company’s financial instruments (cash and cash equivalents) approximate their fair value because of the short maturity of these instruments.

NOTE I - STOCK BASED COMPENSATION:

The Company complies with FASB Accounting Standards Codification, “Compensation-Stock Compensation,” (ASC 718) which requires expense for all share-based payments to employees, including grants of employee stock options, to be recognized in the income statement based on their fair values. Pro forma disclosure is no longer an alternative. For the Company, this statement was effective as of April 1, 2006. The Company adopted the modified prospective method, under which compensation cost is recognized beginning with the effective date. The modified prospective method recognizes compensation cost based on the requirements of ASC 718 for all share-based payments granted after the effective date and, based on the requirements of ASC 718, for all awards granted to employees prior to the effective date that remain unvested on the effective date. The Company was not required to record any expenses under ASC 718 for share based awards currently outstanding. However, the amount of expense recorded under ASC 718 will depend upon the number of share based awards granted in the future and their valuation.

NOTE J – SHAREHOLDERS’ EQUITY

NOTE K – SUBSEQUENT EVENTS

On January 21, 2010, the St. Lawrence Seaway Corporation (“St.L”) (Bulletin Board “STLS”) signed an agreement with T-3 Therapeutics, LLC (“T-3”) for the sale of St. L’s (Medical Investment’s) membership interest in T-3 for $100,000 payable in cash upon execution of the agreement. (See Page 2 – Recent Developments)

The interim financial statements were approved by management and were issued on February 9, 2010. Subsequent events have been evaluated through this date.

Item 2. Management's Discussion and Analysis of Operations / Plan of Operation

Please see "Footnote D -- Medical Investment" in the Notes to the Financial Statements of this Form 10-Q for a description of the medical investments the Company made during 2002 and subsequent additional investments and the write-off of such investments in the year ended March 31, 2008 and its current status.

Please see Page 2 (Recent Developments) for information concerning the sale of the T-3 Therapeutics medical investment and the subsequent redemption of the Class A Tracking Stock.

Results of Operations for the three months ended December 31, 2009 as compared to three months ended December 31, 2008.

Interest income decreased to $ 202 for the three months ended December 31, 2009, from $ 508 for the three months ended December 31, 2008. This decrease is a result of lower cash balances during the three months of 2009 as compared to 2008 and lower interest rates received on invested funds.

General and administrative expenses increased to $8,081 for the three months ended December 31, 2009 from $7,510 for the three months ended December 31, 2008. The increase in general and administrative expenses is primarily due to an increase in administrative items and stockholder expenses.

Results of Operations for the nine months ended December 31, 2009 as compared to nine months ended December 31, 2008.

Interest income in the nine months ended December 31, 2009 was $742 decreasing from $1,747 in the nine months ended December 31, 2008 as a result of lower cash balances and lesser interest rates received on invested funds. General and administrative expenses increased to $24,886 in the nine months ended December 31, 2009 from $22,765 in the same nine months of 2008. The increase is primarily due to an increase in administrative items and stockholder expenses.

Liquidity and Capital Resources

Please see “Recent Developments”, page. 1, and "Note C to the Financial Statements contained under Item 1 of this Form 10-Q for a description of the Purchase Agreement described herein.

Cash and cash equivalents increased from $53,175 at June 30, 2007 to $58,442 at December 31, 2009. At March 31, 2009 cash and cash equivalents was $83,916. The cash decrease from March 31, 2009 to December 31, 2009 was due to the loss incurred in the nine months ended December 31, 2009 and payment of accrued expenses. Most significantly, cash increased from June 30, 2007 to December 31, 2009 in connection with the equity purchases made on August 31, 2007, which were made pursuant to the Purchase Agreement and in connection with the exercise of warrants to purchase 16,667 shares of the Company’s common stock at $3.00 per share made by Mr. Joel Greenblatt, the former Chairman of the Board, offset by expenses in connection with the transaction described herein and offset by cash losses sustained in the Company’s operations in the nine months ended December 31, 2009 and in the years ended March 31, 2008 and 2009. The Company does not have a formal arrangement with any bank or financial institution with respect to the availability of financing in the future.

PLAN OF OPERATION

The Company currently has limited operations. The Company plans to continue as a public entity and continues to seek merger, reverse merger, acquisition and business combination opportunities with operating businesses or other appropriate financial transactions. Until such an acquisition or business combination is effectuated, the Company does not expect to have significant operations. Accordingly, during such period, the Company may not achieve sufficient income to offset its operating expenses, which would cause operating losses that may require the Company to use and thereby reduce its cash on hand.

FORWARD LOOKING STATEMENTS

Certain statements in this Report are “forward-looking statements” within the meaning of the Private Securities Litigation Reform act of 1995. When used in this Report, words such as “may,” “should,” “seek,” “believe,” “expect,” “anticipate,” “estimate,” “project,” “plan,” “goal,” “intend,” “strategy,” and similar expressions are intended to identify the Company’s future plans, operations ,business strategies, operating results, and financial position. Forward-looking statements are subject to a number of known and unknown risks and uncertainties that could cause the Company’s actual results, performance or achievements to differ materially from those described or implied in the forward-looking statement and cause its goals and strategies to not be achieved.

These risks and uncertainties many of which are not within our control, include, but are not limited to:

·	general economic and business conditions;

·	the Company’s ability to find a candidate for, enter into an agreement with respect to, and consummate, a merger, reverse merger, acquisition or business combination or other financial transaction that is acceptable, both as to a candidate and as to transaction terms and conditions;

·	competition for transactions of the nature the Company is seeking;

·	potential future regulatory restrictions that could limit or pose restrictions on, or make less advantageous to potential candidates, transactions of the nature the Company is seeking; and

·	the availability of additional financing on satisfactory terms if a delay is encountered in consummating a transaction that the Company is seeking.

You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date of this Report. We do not undertake any responsibility to publicly update or revise any forward-looking statement or report.

Item 3. Controls and Procedures.

As of the end of the period covered by this Report, the Company’s President, principal executive officer and principal financial officer, evaluated the effectiveness of the company’s “disclosure controls and procedures”, as defined in Rule 13a-15(e) and 15(d)-15(e) under the Securities Exchange Act of 1934. Based on that evaluation, this officer concluded that, as of the date of his evaluation, the Company’s disclosure controls and procedures were effective to provide reasonable assurance that information required to be disclosed in the Company’s periodic filings under the Securities Exchange Act of 1934 is accumulated and communicated to management, including that officer, to allow timely decisions regarding required disclosure. It should be noted that a control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that it will detect or uncover failures within the Company to disclose material information otherwise required to be set forth in the Company’s periodic reports.

During the period covered by this Report, there were no changes in the Company’s internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

PART II. OTHER INFORMATION

Item 1. Legal Proceeding - Not Applicable .

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

Pursuant to the Purchase Agreement with the Investor, on August 31, 2007, the Company sold 75,000 unregistered shares of common stock, par value $0.01 (the “Common Stock”), for $1.00 per share (for a total of $75,000) and 250,000 warrants to purchase 250,000 shares of Common Stock for $0.01 per warrant (for a total of $2,500), as described in Form 8-K, filed by the Company on September 6, 2007. The warrants are exercisable immediately with an exercise price of $1.00 per share.

On August 31, 2007, Mr. Joel Greenblatt, the former Chairman of the board of directors of the Company, exercised warrants to purchase 16,667 shares of Common Stock at $3.00 per share (for a total of $50,001). On June 13, 2006, Mr. Greenblatt exercised warrants to purchase 16,667 shares of Common Stock at $3.00 per share (for a total of $50,001).

All outstanding options and warrants expired on September 21, 2007 (with the exception of the Warrants issued on August 31, 2007 to the Investor in connection with the transaction described under Recent Developments, page 1).

Item 3. Defaults upon Senior Securities - Not Applicable

Item 4. Submission of Matters to a Vote of Security Holders – See Form 8-K, filed by the Company on September 6, 2007, for a description of the transaction outlined on Page 1 of this Form 10-Q. Also please refer to the notice of annual meeting and the proxy statement mailed to all shareholders on May 30, 2007 on Form DEF-14A for a description of all proposals submitted to the shareholders for a vote at the Annual Meeting of Shareholders held on July 10, 2007. All proposals were approved by a majority vote of the shareholders.

Item 5. Other Information – Not Applicable.

Item 6. Exhibits

31.1 -	Certification by Principal Executive Officer and Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1 -	Certificate of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	ST. LAWRENCE SEAWAY CORPORATION Registrant


Dated: February 9, 2010	Bernard Zimmerman Chairman, President, Principal Executive Officer and Principal Financial Officer

Attached files

Stock widget

Investing forum

Carbon Energy Corp Reports

Also read